—
Cell Therapy Market Major Key PlayersSome of key the players in the cell therapy market are Novartis AG, GlaxoSmithKline plc, MEDIPOST, Osiris, PHARMICELL, NuVasive, Inc., JCR Pharmaceuticals Co., Ltd, ANTEROGEN.CO.,LTD., Cynata, CELLECTIS, BioNTech IMFS, EUFETS GmbH, Cognate, Pluristem, Grupo Praxis, Genzyme Corporation, Advanced Tissue and others. Cell therapy is a set of technologies that rely on replacing dysfunctional cells with functioning ones. Cell therapy is based on ground-breaking scientific discoveries and various technological advancements. With new technologies and different types of cells such as hematopoietic stem cells (HSC), mesenchymal stem cells, skeletal muscle stem cells, lymphocytes, pancreatic islet cells, and dendritic cells, cell therapy can be used for the treatment of a variety of diseases. Potential applications of cell therapy include treatment of cancers, urinary problems, autoimmune disease, and infectious disease, repairing spinal cord injuries, rebuilding damaged cartilage in joints, improving the immune system, and treatment of neurological disorders.
Get Sample Copy @
https://www.marketresearchfuture.com/sample_request/5066
Cell therapy is a set of technologies that rely on replacing dysfunctional cells with functioning ones. Cell therapy is based on ground-breaking scientific discoveries and various technological advancements. With new technologies and different types of cells such as hematopoietic stem cells (HSC), mesenchymal stem cells, skeletal muscle stem cells, lymphocytes, pancreatic islet cells, and dendritic cells, cell therapy can be used for the treatment of a variety of diseases. Potential applications of cell therapy include treatment of cancers, urinary problems, autoimmune disease, and infectious disease, repairing spinal cord injuries, rebuilding damaged cartilage in joints, improving the immune system, and treatment of neurological disorders.
A number of factors such as increasing geriatric population, increasing government assistance, replacement of animal testing model, technological advancements, and improvement in the regulatory framework, are propelling the growth of cell therapy market. Rising prevalence of chronic disorders is also fuelling up the market to a great extent.
Despite these drivers, there are some issues associated with cell therapy market. Challenges in research and development, the high cost of manufacturing, and poor healthcare system in low and middle-income countries may hamper the growth of the market.
It is estimated that cell therapy market is expected to grow at a CAGR 10.6% during the forecast period of 2017-2023.
Cell Therapy Market Segmentation
The cell therapy market is segmented on the basis of type, technology, cell source, application, and end-user.
On the basis of type, the market is segmented into autologous, and allogeneic.
On the basis of technology, the market is classified into somatic cell technology, cell immortalization technology, viral vector technology, genome editing technology, cell plasticity technology, and three-dimensional technology. Viral vector technology is further segmented into Ex vivo gene modification of cells and In vivo gene modification of cells.
On the basis of cell source, the market is classified into induced pluripotent stem cells (iPSCs), bone marrow, umbilical cord blood-derived cells, adipose tissue, and neural stem cell.
On the basis of application, the market is classified into musculoskeletal, cardiovascular, gastrointestinal, neurological, oncology, dermatology, wounds and injuries, ocular, and others.
On the basis of end-users, the market is segmented into hospital & clinics, regenerative medicine centers, diagnostic centers, research institutes, and others.
Cell Therapy Market Regional Analysis
The Americas dominate the cell therapy market owing to the rise in awareness among people, and high healthcare expenditure.
Europe holds the second position in cell therapy market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region. On August 30, 2017. Novartis AG, A Switzerland based market leader, received FDA approval for Kymriah suspension for intravenous infusion. It is the first chimeric antigen receptor T cell therapy (CAR-T).
The Asia Pacific is the fastest growing cell therapy market owing to the huge patient pool and developing healthcare technology.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/5066
Detailed Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
LIST OF TABLES
Table 1 Cell Therapy Industry Synopsis, 2017 – 2023
Table 2 Cell Therapy Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Cell Therapy Market By Region, 2017 – 2023, (USD Million)
Table 4 Cell Therapy Market By Type, 2017 – 2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Cell Therapy Market
Figure 3 Segmentation Market Dynamics For Cell Therapy Market
Figure 4 Global Cell Therapy Market Share, By Type 2016
...Continued
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/5066
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com
Release ID: 395738